Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127104341 | 12710434 | 1 | I | 20160606 | 20160825 | 20160902 | 20160902 | EXP | JP-AMGEN-JPNCT2016116324 | AMGEN | 64.00 | YR | A | M | Y | 45.00000 | KG | 20160902 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127104341 | 12710434 | 1 | PS | darbepoetin alfa | DARBEPOETIN ALFA | 1 | Subcutaneous | 60 MUG, Q4WK | 103951 | 60 | UG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 127104341 | 12710434 | 2 | SS | darbepoetin alfa | DARBEPOETIN ALFA | 1 | Subcutaneous | 60 MUG, UNK | 103951 | 60 | UG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 127104341 | 12710434 | 3 | SS | darbepoetin alfa | DARBEPOETIN ALFA | 1 | Subcutaneous | 90 MUG, UNK | 103951 | 90 | UG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 127104341 | 12710434 | 4 | SS | darbepoetin alfa | DARBEPOETIN ALFA | 1 | Subcutaneous | 120 MUG, Q4WK | 103951 | 120 | UG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 127104341 | 12710434 | 5 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
| 127104341 | 12710434 | 6 | SS | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | Oral | 3.27 G, BID | 0 | 3.27 | G | SYRUP | BID | ||||||
| 127104341 | 12710434 | 7 | SS | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Unknown | 5 G, BID | 0 | 5 | G | BID | |||||||
| 127104341 | 12710434 | 8 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 50 MG, QD | 0 | 50 | MG | TABLET | QD | ||||||
| 127104341 | 12710434 | 9 | SS | CALFINA | ALFACALCIDOL | 1 | Oral | 0.25 MUG, QD | 0 | .25 | UG | TABLET | QD | ||||||
| 127104341 | 12710434 | 10 | SS | ARTIST | CARVEDILOL | 1 | Oral | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
| 127104341 | 12710434 | 11 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 127104341 | 12710434 | 12 | SS | CALTAN | CALCIUM CARBONATE | 1 | Oral | 1000 MG, TID | 0 | 1000 | MG | TID | |||||||
| 127104341 | 12710434 | 13 | SS | ZONISAMIDE. | ZONISAMIDE | 1 | Oral | 100 MG, BID | 0 | 100 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127104341 | 12710434 | 1 | Chronic kidney disease |
| 127104341 | 12710434 | 5 | Hypertension |
| 127104341 | 12710434 | 6 | Hyperkalaemia |
| 127104341 | 12710434 | 7 | Acidosis |
| 127104341 | 12710434 | 8 | Hyperuricaemia |
| 127104341 | 12710434 | 9 | Hyperparathyroidism secondary |
| 127104341 | 12710434 | 10 | Hypertension |
| 127104341 | 12710434 | 11 | Hypertension |
| 127104341 | 12710434 | 12 | Hyperphosphataemia |
| 127104341 | 12710434 | 13 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127104341 | 12710434 | DS |
| 127104341 | 12710434 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127104341 | 12710434 | Gout | |
| 127104341 | 12710434 | Haemodialysis | |
| 127104341 | 12710434 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127104341 | 12710434 | 1 | 20150805 | 0 | ||
| 127104341 | 12710434 | 2 | 20151230 | 0 | ||
| 127104341 | 12710434 | 3 | 20160127 | 0 | ||
| 127104341 | 12710434 | 4 | 20160224 | 0 | ||
| 127104341 | 12710434 | 5 | 20150513 | 0 | ||
| 127104341 | 12710434 | 6 | 20130612 | 0 | ||
| 127104341 | 12710434 | 7 | 20150613 | 0 | ||
| 127104341 | 12710434 | 8 | 20160513 | 0 | ||
| 127104341 | 12710434 | 9 | 20151230 | 0 | ||
| 127104341 | 12710434 | 10 | 20160224 | 0 | ||
| 127104341 | 12710434 | 11 | 20160513 | 0 | ||
| 127104341 | 12710434 | 12 | 20160513 | 0 | ||
| 127104341 | 12710434 | 13 | 2003 | 0 |